Cargando…
Retracted: Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711977/ https://www.ncbi.nlm.nih.gov/pubmed/36465246 http://dx.doi.org/10.1155/2022/9834370 |
| _version_ | 1784841694930272256 |
|---|---|
| author | Engineering, Journal of Healthcare |
| author_facet | Engineering, Journal of Healthcare |
| author_sort | Engineering, Journal of Healthcare |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9711977 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97119772022-12-01 Retracted: Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate Engineering, Journal of Healthcare J Healthc Eng Retraction Hindawi 2022-11-23 /pmc/articles/PMC9711977/ /pubmed/36465246 http://dx.doi.org/10.1155/2022/9834370 Text en Copyright © 2022 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Engineering, Journal of Healthcare Retracted: Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate |
| title | Retracted: Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate |
| title_full | Retracted: Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate |
| title_fullStr | Retracted: Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate |
| title_full_unstemmed | Retracted: Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate |
| title_short | Retracted: Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate |
| title_sort | retracted: efficacy of crizotinib combined with chemotherapy in treating advanced non-small-cell lung cancer and effect on patients' quality of life and adverse reaction rate |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711977/ https://www.ncbi.nlm.nih.gov/pubmed/36465246 http://dx.doi.org/10.1155/2022/9834370 |
| work_keys_str_mv | AT engineeringjournalofhealthcare retractedefficacyofcrizotinibcombinedwithchemotherapyintreatingadvancednonsmallcelllungcancerandeffectonpatientsqualityoflifeandadversereactionrate |